| scholarly article | Q13442814 |
| P50 | author | Hirohito Sone | Q39956334 |
| P2093 | author name string | Atsunori Kashiwagi | |
| Hitoshi Shimano | |||
| Yoriko Heianza | |||
| Akiko Suzuki | |||
| Hiroaki Yagyu | |||
| Shiro Tanaka | |||
| Kazuya Fujihara | |||
| Osamu Hanyu | |||
| Hiroki Yokoyama | |||
| Koichi Kawai | |||
| Takaho Yamada | |||
| Katuya Yamazaki | |||
| P2860 | cites work | Efficacy of metformin in the treatment of NIDDM. Meta-analysis | Q22241285 |
| Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Q22241288 | ||
| Japanese universal health coverage: evolution, achievements, and challenges | Q28246970 | ||
| International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values | Q33585669 | ||
| Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32). | Q34299670 | ||
| Thiazolidinediones | Q34346862 | ||
| The role of incretins in glucose homeostasis and diabetes treatment | Q34901533 | ||
| Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial | Q34985342 | ||
| Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications | Q35141566 | ||
| Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes | Q35962994 | ||
| Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide | Q36718446 | ||
| Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. | Q36945255 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. | Q37312905 | ||
| GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Q38040314 | ||
| Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar | Q38058457 | ||
| Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis | Q38076330 | ||
| Trends in antidiabetic prescription patterns in Japan from 2005 to 2011. | Q39418578 | ||
| Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes | Q40586493 | ||
| Acarbose: its role in the treatment of diabetes mellitus | Q41206503 | ||
| Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database | Q43064817 | ||
| A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey | Q44729166 | ||
| Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study | Q45420482 | ||
| Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. | Q45924271 | ||
| Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice | Q46664820 | ||
| The status of diabetes control and antidiabetic drug therapy in Japan--a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). | Q50112660 | ||
| Use of antidiabetic drugs in the U.S., 2003-2012. | Q50126883 | ||
| Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. | Q51569209 | ||
| Type 2 diabetes-a matter of beta-cell life and death? | Q53873519 | ||
| P433 | issue | 2 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 260-269 | |
| P577 | publication date | 2015-07-26 | |
| P1433 | published in | Journal of Diabetes Investigation | Q28207066 |
| P1476 | title | Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists | |
| P478 | volume | 7 |
| Q52571293 | Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus. |
| Q90602779 | Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians' Perspective in a Real-World Setting, Insight from a Web Survey |
| Q37656347 | Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42). |
| Q60309520 | Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes |
| Q47278884 | Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A Protocol. |
Search more.